|
Selkova E.P., Aleshkin V.A., Grenkova T.A., Katlinsky A.V., Polezhaeva N.A., Suranova T.G., Lapickaya A.S.
The results of influenza immunoprophylaxis in the 2015–2016 epidemic season
|
№1 / 2017
|
|
Selkova E.P., Grenkova T.A., Aleshkin V.А., Gudova N.V., . Lytkina I.N., Mikhailova E.V., Yashina A.Ya., Fedyakina I.T.
Investigation of the immunogenicity, efficacy, and tolerability of the Russian vaccine Ultrix® among people at high risk for the infection and morbidity of influenza and acute respiratory viral infections
|
№1 / 2016
|
|
Selkova E.P., Grenkova T.A., Gudova N.V., Oganesyan A.S., Polezhaeva N.A.
Epidemiological importance of influenza vaccination. Russian new-generation influenza vaccine
|
№4 / 2014
|
|
Raduto O.I.
Clinical and economic aspects of parenteral hepatitis C
|
№3 / 2014
|
|
Yermalovich M.A.
The etiological pattern of viral exanthems in children less than 4 years of age in Belarus
|
№1 / 2014
|
|
Shaginyan V.R., Gural A.L., Sergeeva T.A., Maksimenok E.V., Myshko O.V., Sadkova A.B.
The immunological and epidemiological efficiency of hepatitis B vaccination: Multicenter study results
|
№4 / 2013
|
|
Briko N.I.
Vaccination is a decisive measure to reduce the burden associated with infectious diseases among adults
|
№4 / 2013
|
|
Semenenko T.A., Rusakova E.V., Shcherbakov A.G., Gaidarenko A.D., Gotvyanskaya T.P., Evseyeva L.F., Sipacheva N.B., Guseva E.V., Nikitina G.Yu., Shaposhnikov A.A.
Herd immunity against controlled infections (according to the materials of the serum bank)
|
№6 / 2012
|
|
Romanenko V.V., Ankudinova A.V., Averyanov O.Yu., Chebykina T.V., Spesivtseva L.Yu.
Results of a clinical trial of the safety and efficacy profile of the trivalent inactivated polymer-subunit influenza vaccine Grippol® plus for infants aged 6 months to 3 years
|
№5 / 2012
|
|
Feldblyum I.V.
Prophylactic vaccination as life- saving technology and a tool of demographic policy
|
№2 / 2011
|
Русский
